Latest filing published 19 Dec 2025 for Monopar Therapeutics, €266k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Arthur J. Klausner: trading record in brief
This profile gathers the share dealings of Arthur J. Klausner in Monopar Therapeutics, where the filings describe the role as board member. We count 19 filings; the first trade dates from 31 March 2020 and the latest from 18 December 2025.
On the market, this insider has only sold: 2 sales, €293k in total. Besides market trades, the filings include 16 option exercises. 2025 to date brings no purchases and 2 sales.
On 19 December 2025 came the latest disclosure, an open-market sale for €27k in Monopar Therapeutics. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Arthur J. Klausner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,660 shares@ US$67.06100.0% of flowCommon StockSEC:0001437749-25-038426:0
- 7,710 shares0Common StockSEC:0001437749-25-038138:0
- 2,533 sharesCommon StockSEC:0001437749-24-000484:0
- 2,533 sharesCommon StockSEC:0001437749-23-027585:0
- 2,534 sharesCommon StockSEC:0001437749-23-019260:0
- 2,533 sharesCommon StockSEC:0001437749-23-009336:0
- 2,859 sharesCommon StockSEC:0001437749-23-000171:0
- 2,859 sharesCommon StockSEC:0001654954-22-013279:0
- 2,859 sharesCommon StockSEC:0001654954-22-009151:0
- 2,859 sharesCommon StockSEC:0001654954-22-004481:0
- 751 sharesCommon StockSEC:0001654954-22-000114:0
- 751 sharesCommon StockSEC:0001654954-21-010716:0
- 752 sharesCommon StockSEC:0001654954-21-007599:0
13 of 13 declarations
